Crinetics Pharmaceuticals Inc buy Robert W. Baird
Start price
29.02.24
/
50%
€38.00
Target price
28.02.25
€47.97
Performance (%)
29.47%
Price
12.07.24
€49.20
Summary
This prediction is currently active. The prediction currently has a performance of 29.47%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | - | - |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by Robert_W__Baird for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Robert W. Baird from $45.00 to $52.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Robert_W__Baird for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€45.00
23.05.24
23.05.24
€57.32
23.05.25
23.05.25
9.33%
12.07.24
12.07.24
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€25.00
11.09.23
11.09.23
€41.82
11.09.24
11.09.24
96.80%
12.07.24
12.07.24
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€14.90
29.03.23
29.03.23
-
29.03.24
29.03.24
191.28%
30.03.24
30.03.24